Status:

COMPLETED

Clinical Evaluation of the Accuracy of the FreeStyle Navigator Continuous Glucose Monitoring System

Lead Sponsor:

Abbott Diabetes Care

Conditions:

Diabetes Mellitus

Eligibility:

All Genders

18+ years

Brief Summary

To evaluate the clinical accuracy of the FreeStyle Navigator Continuous Glucose Monitoring System with respect to a reference standard.

Eligibility Criteria

Inclusion

  • History consistent with type 1 diabetes
  • At least 18 years of age
  • Available and capable of following the protocol instructions provided by the healthcare professional
  • Signed and dated informed consent form

Exclusion

  • Pregnancy
  • Type 2, gestational, or secondary diabetes
  • Known allergy to medical grade adhesives
  • Skin abnormalities at the insertion sites that would confound the assessment of the effect of the device on the skin
  • Seizure disorder
  • Myocardial ischemia
  • History of stroke
  • Severe hypoglycemia unawareness
  • Other concomitant medical conditions that in the opinion of the investigator, would affect the evaluation of device performance and/or safety

Key Trial Info

Start Date :

November 1 2005

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 1 2005

Estimated Enrollment :

58 Patients enrolled

Trial Details

Trial ID

NCT00920881

Start Date

November 1 2005

End Date

December 1 2005

Last Update

June 15 2009

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Diablo Clinical Research

Walnut Creek, California, United States, 94598

2

Diabetes & Glandular Disease Clinic

San Antonio, Texas, United States, 78229

3

Ranier Clinical Research

Renton, Washington, United States, 98055